Vasopressor agent

This page covers all Vasopressor agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin II receptor (AT1 and AT2), Vasopressin receptor (V1 and V2), V1 vasopressin receptor.

Targets

Angiotensin II receptor (AT1 and AT2) · Vasopressin receptor (V1 and V2) · V1 vasopressin receptor · V1 and V2 vasopressin receptors · V1 receptor

Marketed (3)

• Angiotensin II Infusion · Massachusetts General Hospital · Cardiovascular / Critical Care
  Angiotensin II directly binds to angiotensin II receptors (AT1 and AT2) on vascular smooth muscle and other tissues to increase vasoconstriction and blood pressure.
• vasopressin - early initiation · The Cleveland Clinic · Critical Care / Sepsis
  Vasopressin is a naturally occurring hormone that binds to vasopressin receptors to increase blood pressure and vasoconstriction, used in early septic shock management to restore hemodynamic stability.
• Intracervical injection of Vasopressin · Prisma Health-Upstate · Gynecology
  Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue.

Phase 3 pipeline (2)

• Administration of AVP · Assistance Publique - Hôpitaux de Paris · Critical Care / Intensive Care Medicine
  AVP is an arginine vasopressin analog that acts as a vasopressor agent to increase blood pressure and peripheral vascular resistance.
• Early Vasopressin · Hospital do Coracao · Critical Care / Cardiovascular
  Early Vasopressin is a vasopressin analog that acts as a vasoconstrictor to increase blood pressure and peripheral vascular resistance in acute hypotensive states.